Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Ocean Biomedical, Inc.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/31/2023 |
8-K/A
| Financial Statements and Exhibits Interactive Data
Docs:
|
"OCEAN BIOMEDICAL, INC. AND SUBSIDIARIES INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm F-2 Consolidated Financial Statements Consolidated Balance Sheets F-3 Consolidated Statements of Operations F-4 Consolidated Statements of Stockholders’ Equity F-5 Consolidated Statements of Cash Flows F-6 Notes to Consolidated Financial Statements F-7 - F-25 F- 1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the shareholders and the Board of Directors of Ocean Biomedical, Inc. Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of Ocean Biomedical, Inc. and subsidiaries as of December 31, 2022 and 2021, the related consolidated statements of operations, stockholders’ deficit, and cash flows...",
"OCEAN BIOMEDICAL’ S MANAGEMENT’ S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS",
"UNAUDITED PRO FORMA COMBINED CONsolidated FINANCIAL INFORMATION Introduction The following unaudited pro forma combined financial information presents the combination of the financial information of Aesther Healthcare Acquisition Corp. and Ocean Biomedical, Inc. adjusted to give effect to a completed transaction on February 14, 2023 , whereas, AHAC consummated the Agreement and Plan of Merger dated August 31, 2022 as amended on December 5, 2022 . On the Closing Date, AHAC Merger Sub Inc., a Delaware corporation and wholly-owned subsidiary of AHAC merged with and into Ocean Biomedical, Inc., with Ocean Biomedical, Inc., continuing as the surviving entity and a wholly-owned subsidiary of AHAC . In connection with the closing of the Business Combination , AHAC changed its name from “Aesther H..." |
|
|
|